AGRX

Agile Therapeutics (AGRX)

Agile Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:AGRX

<< 이전 1 2 3 4 5 6 7 8 9 10 11 12 13 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2022/11/15	06:52	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGRX	Agile Therapeutics Inc
2022/11/15	06:50	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGRX	Agile Therapeutics Inc
2022/11/15	06:50	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGRX	Agile Therapeutics Inc
2022/11/10	16:45	TipRanks	Agile Therapeutics (AGRX) Gets a Buy from Maxim Group	NASDAQ:AGRX	Agile Therapeutics Inc
2022/11/10	07:06	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:AGRX	Agile Therapeutics Inc
2022/11/08	06:21	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:AGRX	Agile Therapeutics Inc
2022/11/08	06:05	GlobeNewswire Inc.	Agile Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update	NASDAQ:AGRX	Agile Therapeutics Inc
2022/10/26	21:30	GlobeNewswire Inc.	Agile Therapeutics to Report Third Quarter 2022 Financial Results and Provide Business Update on Monday, November 7, 2022	NASDAQ:AGRX	Agile Therapeutics Inc
2022/10/08	05:32	TipRanks	Agile Therapeutics appoints Amy Welsh to chief commercial officer	NASDAQ:AGRX	Agile Therapeutics Inc
2022/10/08	05:31	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AGRX	Agile Therapeutics Inc
2022/10/08	05:25	GlobeNewswire Inc.	Agile Therapeutics Announces Reorganization of Leadership Team	NASDAQ:AGRX	Agile Therapeutics Inc
2022/09/28	02:15	TipRanks	Maxim Group Keeps Their Buy Rating on Agile Therapeutics (AGRX)	NASDAQ:AGRX	Agile Therapeutics Inc
2022/09/06	21:30	GlobeNewswire Inc.	Agile Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference	NASDAQ:AGRX	Agile Therapeutics Inc
2022/08/29	21:31	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGRX	Agile Therapeutics Inc
2022/08/25	05:31	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AGRX	Agile Therapeutics Inc
2022/08/20	05:31	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AGRX	Agile Therapeutics Inc
2022/08/13	23:15	TipRanks	Maxim Group Reaffirms Their Buy Rating on Agile Therapeutics (AGRX)	NASDAQ:AGRX	Agile Therapeutics Inc
2022/08/12	05:22	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:AGRX	Agile Therapeutics Inc
2022/08/12	05:11	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AGRX	Agile Therapeutics Inc
2022/08/12	05:05	GlobeNewswire Inc.	Agile Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update	NASDAQ:AGRX	Agile Therapeutics Inc
2022/07/28	21:05	GlobeNewswire Inc.	Agile Therapeutics to Report Second Quarter 2022 Financial Results and Provide Business Update on Thursday, August 11, 2022	NASDAQ:AGRX	Agile Therapeutics Inc
2022/07/13	06:01	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:AGRX	Agile Therapeutics Inc
2022/07/12	21:05	GlobeNewswire Inc.	Agile Therapeutics Updates Second Quarter 2022 Guidance	NASDAQ:AGRX	Agile Therapeutics Inc
2022/07/11	20:55	TipRanks	Agile Therapeutics (AGRX) Receives a Buy from H.C. Wainwright	NASDAQ:AGRX	Agile Therapeutics Inc
2022/07/09	06:17	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AGRX	Agile Therapeutics Inc
2022/07/08	21:05	GlobeNewswire Inc.	Agile Therapeutics to Participate in Maxim Group’s Upcoming Women’s Health Panel	NASDAQ:AGRX	Agile Therapeutics Inc
2022/07/07	06:16	GlobeNewswire Inc.	Agile Therapeutics Announces Closing of $24 Million Upsized Public Offering	NASDAQ:AGRX	Agile Therapeutics Inc
2022/07/01	22:20	GlobeNewswire Inc.	Agile Therapeutics Announces Pricing of $24 Million Upsized Public Offering	NASDAQ:AGRX	Agile Therapeutics Inc
2022/07/01	22:05	Edgar (US Regulatory)	Registration of Additional Securities (up to 20%) (s-1mef)	NASDAQ:AGRX	Agile Therapeutics Inc
2022/06/11	05:49	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGRX	Agile Therapeutics Inc